This article needs additional citations for verification. (March 2020) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Pharmacokinetic data | |
Metabolism | N-demethylation[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.332 |
Chemical and physical data | |
Formula | C13H17N3O |
Molar mass | 231.299 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Aminophenazone (or aminopyrine, amidopyrine, Pyramidon) is a non-narcotic analgesic substance. It is a pyrazolone and a derivative of phenazone, which also has anti-inflammatory and antipyretic properties. While inexpensive and effective, especially in the treatment of rheumatism, the drug carries a serious risk of severe and sometimes fatal side-effects, including agranulocytosis.[citation needed] While its production and use have been banned in many countries, including France, Thailand, India and Japan, it is still sometimes used in the developing world.[citation needed]
A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of cytochrome P-450 metabolic activity in liver-function tests.[1] It is also used in measuring the total body water in the human body system.[2]